Neonatal humans are unusually susceptible to severe and often fatal HSV infections ( 1 ). The immunologic defect that explains their susceptibility to this common viruiin the first months of life with development of resistance in the second half of the first year of life remains to be elucidated (1, 2). As in humans, neonatal mice are extremely susceptible to fatal HSV infection (3) . We have developed a murine model of neonatal HSV infection in which infant mice can be nearly completely protected from an otherwise lethal HSV infection by a combination of human antiviral antibody, human natural or recombinant DNA a-interferon, and human mononuclear leukocytes (4) (5) (6) . None of these factors by itself was protective. While leukocytes from adult humans could confer this protection, those obtained from umbilical cord blood were unable to protect in combination with either antibody (7) or antibody and interferon (4). We have now studied the development of the ability of leukocytes obtained toxic titer was using human adult mononuclear leukocyte from infants in the first year of life to protect mice from lethal effector cells (30: 1 effector to target ratio) in a 4-h assay (4, 5, 7) . HSV infection in this model. The ontogeny of this leukocyte
Mice. All experiments were performed in I-wk-old C57BL/6 function appears to parallel the ontogeny of the resistance of mice obtained from Timco Breeding Laboratories, Houston, TX. humans to HSV infection.
Virus. HSV type 1, HE strain, originally isolated in the laboratory of Dr. Andre Nahmias, Atlanta, GA, from a neonate with HSV infection, was used throughout.
MATERIALS AND METHODS
Adoutive transfer model. One-week-old mice were randomly Leukocytes. All human experiments were performed after obtaining informed consent according to the guidelines of the Committee for the Protection of Human Subjects of the University of Texas Health Science Center, Houston, and the National Institutes of Health. One to 2 ml of heparinized (10 unitslml; Upjohn, Kalamazoo, MI) blood was obtained from 13 various ages healthy infants at the time of venipuncture for routine health care maintenance tests (phenylketonuria screening tests, hemaglobin determinations, etc.). Four of these infants were tested twice (numbers 2, 5, 6, and 7, Table 1 ). A sample of similar volume from one of eight different healthy adult controls was simultaneously obtained. Leukocytes were separated by Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) centrifugation. MC leukocytes were washed three times in Hank's balanced salt solution (GIBCO, Grand Island, NY), and suspended in minimal essential media (GIBCO, 1 x lo7 leukocytes/ ml) containing antibody and interferon (4-7).
Interferon. Purified human recombinant DNA produced IFLrA was kindly provided by Dr. Patrick Trown, HoffmannLaRoche, Inc., Nutley, NJ. The preparation and characterization of this have been previously described (8, 9) .
Antibody. Antibody was heat-inactivated immune serum globulin (lot number NFOO 13-1, Cutter Laboratories, Berkeley, CAI. This is a commercially available cold ethanol fractionation preparation of pooled human serum. The anti-HSV neutralizing titer was 1:2040 and the anti-HSV antibody-dependent cellular cyto- chosen to receive 1 x lo6 leukocytes from babies or adults in media containing 1000 units of IFLrA and a dilution of antibody in a volume of 0.1 ml administered IP. One day later, mice were inoculated with lo5 PFU of HSV IP (1000 LD,,). Animals were observed for mortality for 3 wk. No viral associated deaths occurred after 3 wk (4-7).
Statistical analysis. To take advantage of the pairing of baby and adult blood samples, the difference (A) between the percentage of mice surviving after receiving cells from adult blood and the percentage surviving after receiving cells from baby blood was calculated for each of the 16 groups of mice. One baby (day 199) was not paired and therefore not included in this analysis. Linear regression was used to assess the significance of the relationship between A and age of babies from whom cells were obtained.
Survival plots were constructed for four groups: 17 control mice receiving antibody and IFLrA alone, 66 mice receiving leukocytes from babies less than 130 days old, 50 mice receiving leukocytes from babies greater than 130 days old, and 106 mice receiving leukocytes from adults, all combined with antibody and IFLrA. The four curves were compared using x 2 analysis of survival 2 1 days after infection. Table I (Table 1) .
RESULTS
The survival afforded by cells from adults, cells from babies less than 130 days of age, and cells from babies greater than 130 days of age in combination with antibody and IFLrA; or antibody and IFLrA alone is graphically depicted in Figure 1 .
Linear regression analysis showed a significant relationship (p < 0.02) between age of baby and A survival, the measure of the difference between the protective effect of adult blood and baby blood. A plot of the 16 A survival values along thefitted straight line (Fig. 2) indicates that the protective effect of baby blood approached that of adult blood within the first year. DISCUSSION We have demonstrated that mononuclear leukocytes from adult humans in combination with antiviral antibody and inter-using le;koc$tes obtained from umbilical cord blood, 5 x lo6 or 1 x lo7 leukocytes plus antibody and interferon could not The specific cell mediating the protective effect and the mechanism of protection remains to be elucidated. Preliminary data suggest that the leukocytes found in the large granular lymphocyte portion of Percoll density separations are protective (6) . Protection is entirely independent of the HSV seroimmune status of the cell donor (4, 5). Possible mechanisms include in vivo cytotoxicity against virus-infected cells and/or interferon stimu- to be highly lethal in neonates. It is hoped that further understanding of the present system will allow for either successful immunomodulation or replacement reconstitution in the infant feron could protect neonatal mice from otherwise lethal HSV at high risk for neonatal HSV infection. Combination chemoinfection (4; Table 1 ). Cells from healthy human infants dem-therapy and immune reconstitution have been shown to be onstrated an age-dependent defect in this function. There was additive in animal models of HSV infection (14) . some variability of protection by cells as can be seen in Figure 2 and Table 1 ABSTRACT. The use of a multiple gas rebreathing method for the measurement of cardiopulmonary function in mechanically ventilated neonates was evaluated. The following indices of cardiopulmonary function were assessed in 20 piglets (mean weight, 2.3 kg): 1) pulmonary capillary blood flow ( a ) , 2) diffusing capacity for carbon monoxide (DLco), 3) lung gas volume (FRC), 4) oxygen consumption (Voz), and 5) volume of the pulmonary tissues and capillaries (VTPC), the latter an estimate of total lung water. During mechanical ventilation at zero end expiratory pressure, all rebreathing parameters correlated well with body weight. Additionally, a good correlation ( r = 0.81, slope = 0.99) between VTPC and postmortem estimate of total lung water was observed. The effect of ventilation with positive end expiratory pressure (PEEP) was then studied in 10 piglets. On increasing PEEP from zero to 15 cm H20, FRC significantly increased by 208%, a significantly decreased by 60%, and no changes in W P C occurred. Seven piglets were then studied after induction of lung injury by oleic acid infusion. Compared with the preoleic acid infusion values, all the rebreathing variables decreased during ventilation without PEEP. Unlike the situation with the normal piglets, when PEEP was increased from zero to 10 cm H z 0 in the oleic acid-infused piglets, the values for FRC and VTPC significantly increased. Mean VTPC at 10 cm H z 0 was 20 f 2 ml/kg which correlated well (r = 0.93) with the postmortem total lung water value of 19 f 1 g/kg. Thus, multiple gas rebreathing methodology is applicable to studies using The noninvasive multiple gas rebreathing method (19) allows for easily repeatable, accurate, and rapid measurement of several indices of cardiopulmonary function including Q,, DLco, Vo2, FRC, and VTPC, the latter measurement an accurate estimate of total lung water (10, 12) . This technique has been used in large animals (dogs, sheep) as well as humans (3, 10, 11, 13, 16, 18, 19, 2 1). Presently, the measurement of these cardiopulmonary indices in human neonates, utilizing standard invasive techniques, is limited by the size of the vascular access, the necessity to repetitively disconnect the patient from a ventilator, and by the time required to make the measurements (20).
The purpose of the present study was to evaluate the feasibility of applying rebreathing methodology to piglets, a small animal similar in size to a human neonate, and with collateral ventilation similar to humans (8) . Since PEEP is a commonly used treatment modality in neonatal lung injury, we also evaluated the effects of PEEP on rebreathing parameters in normal piglets and also in piglets with oleic acid-induced lung injury.
